{"tid":471189,"cid":5,"subCid":0,"title":"控方：老闆周向榮責無旁貸","createTime":"2017-11-17T04:28:50.000Z","updateTime":"2017-11-17T04:28:50.000Z","uid":25558,"like":0,"dislike":0,"uniUserReply":1,"replies":[{"pid":"e51065627817fd6d6c39ac917a8d58a140222920","tid":471189,"uid":25558,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2017-11-17T04:28:50.000Z","msg":"<a href=\"https://hk.news.appledaily.com/local/daily/article/20171117/20216768\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fhk.news.appledaily.com%2Flocal%2Fdaily%2Farticle%2F20171117%2F20216768&d=j3GOyvcuxBwnVifK%2BrcsgO9M5Ue6CDmcYDZznX2R1Ws%3D&h=256f9878\" data-ef-url=\"https://embed.lih.kg/frame?u=https%3A%2F%2Fhk.news.appledaily.com%2Flocal%2Fdaily%2Farticle%2F20171117%2F20216768&h=b508802f\" target=\"_blank\">https://hk.news.appledaily.com/local/daily/article/20171117/20216768</a><br />\n<br />\n控方：老闆周向榮責無旁貸<br />\n<br />\n法庭   <br />\n <br />\n    <img src=\"https://static.appledaily.hk/images/apple-photos/apple/20171117/large/17ls3p03.jpg\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fstatic.appledaily.hk%2Fimages%2Fapple-photos%2Fapple%2F20171117%2Flarge%2F17ls3p03.jpg&h=b8927c3f&s={SIZE}\" />    <br />\n<br />\n【DR誤殺案】<br />\n【本報訊】DR醫學美容的CIK免疫細胞療程涉釀成一死兩傷殘，控方昨在高等法院繼續結案陳詞，指負責培植細胞的次被告陳冠忠為取悅老闆周向榮（圖），即使起初未能掌握培植技術，又不夠時間作細菌測試，仍強推產品；而周作為醫生及實驗室話事人，沒制訂監督並確保產品不受污染，可謂責無旁貸。<br />\n<br />\n指明顯想搶先推療程賺錢<br />\n<br />\n主控資深大狀梁偉文提醒陪審員，沒任何科學根據證明CIK療程可抗衰老或增強抵抗力，事主根本不需接受注射，注射只會令她們置身嚴重的細菌感染風險。主控指各被告於2012年2月往廣州學藝返港後，DR即推出療程，內部通告更謂「養X醫院亦推出CIK」，周明顯是希望搶先推出療程賺錢；主控指療程索價5.9萬元，更有顧客為此花費50萬元。<br />\n<br />\n主控指次被告在療程推出後發現培植有困難，向廣州軍區總醫院的肖教授問竅門；而在首名員工接受注射前3天，陳才向同事確認培養液資料，可見培植過程非常粗疏。<br />\n<br />\n至於首被告多番強調培植細胞的亞太幹細胞科研中心有制訂標準作業程序，符合美國血庫協會規格，但主控指所謂的作業程序在案發後一年才製成，旨在粉飾太平，且內容錯漏百出，是粗疏的抄襲成品。控方強調，若任何人憑實驗室的華麗裝修而相信CIK製成品是無菌及符合良好生產標準，實在過於天真。下周一續審。<br />\n<br />\n案件編號：HCCC437/15<br />\n■記者楊思雅"}]}